Award Winner (Service Appreciation Award) 2024: Stephan Krause, PhD

Stephan Krause, PhD

Stephan Krause, PhD

BMS

It is always an honor and much appreciated to be recognized for the extra volunteer work we have put in to advance industry best practices. Recognition always helps us to raise awareness of the value of our volunteer contributions. I will continue my volunteer work in areas of greatest need for advancements of best industry practices, inspired by knowing when my ideas and solutions are used by my peers.

About Stephan Krause, PhD

Stephan O. Krause, PhD, is the Executive Director, Analytical Science and Technology, Cell Therapy Global Quality, at Bristol Myers Squibb. He is an accomplished advocate for advancing industry best practices.
Stephan is currently a member of PDA’s Borard of Directors, chair of PDA’s ATMP Advisory Board, and chair of the ANSI task force (ANS-007) for analytical lifecycle steps. He has won numerous innovation, advocating, and publication awards. Based on his work and leadership, Stephan was invited and presented an industry perspective to major regulatory agencies for the analytical lifecycle and control strategies to support the implementation of ICH Q2(R2), Q12, and Q14.